C5-benzyl SAHA

CAS No. 2115700-64-4

C5-benzyl SAHA( —— )

Catalog No. M13367 CAS No. 2115700-64-4

C5-benzyl SAHA is a C5-modified SAHA analog that displays dual selectivity to HDAC.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    C5-benzyl SAHA
  • Note
    Research use only, not for human use.
  • Brief Description
    C5-benzyl SAHA is a C5-modified SAHA analog that displays dual selectivity to HDAC.
  • Description
    C5-benzyl SAHA is a C5-modified SAHA analog that displays dual selectivity to HDAC6 (IC50=0.27 uM) and HDAC8 (IC50=0.38 uM) over HDAC 1, 2, and 3 (IC50=2.9-5.8 uM); dose dependently and selectively increases in levels of acetyl-α-tubulin in U937 leukemia cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2115700-64-4
  • Formula Weight
    354.45
  • Molecular Formula
    C21H26N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    4-benzyl-N8-hydroxy-N1-phenyloctanediamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Negmeldin AT, et al. Bioorg Med Chem Lett. 2017 Aug 1;27(15):3254-3258.
molnova catalog
related products
  • Panobinostat

    A potent, broad-spectrum HDAC inhibitor with IC50 of 5-20 nM in cell-free assyas.

  • RTS-V5

    RTS-V5 (Dual HDAC-proteasome inhibitor RTS-V5) is the first-in-class, dual HDAC-proteasome inhibitor.

  • CRA-026440

    CRA-026440(PCI-34051) is a highly potent HDAC inhibitor with inhibitory effects on HDAC1, HDAC2, HDAC3, HDAC6, HDAC8 and HDAC10 with Ki values of 4,14,11,15,7 and 20 nM, respectively.